X

Vous n'êtes pas connecté

Maroc Maroc - DRUGS.COM - New Drug Approvals - 19/Jul 19:07

FDA Approves Zituvimet XR (sitagliptin and metformin hydrochloride) Extended-Release Tablets for Adults with Type 2 Diabetes

Ahmedabad, India, 19 July 2024 Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval for its New Drug Application (NDA) from the United States Food and Drug...

Articles similaires

Sorry! Image not available at this time

KalVista Announces FDA Acceptance of New Drug Application for Sebetralstat for Oral On-Demand Treatment of Hereditary Angioedema

drugs.com - 03/Sep 20:09

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--Sep. 3, 2024-- KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the U.S....

Sorry! Image not available at this time

KalVista announces FDA acceptance of NDA for sebetralstat for oral on-demand treatment of HAE

haei.org - 03/Sep 17:29

KalVista announces FDA acceptance of New Drug Application for sebetralstat for oral on-demand treatment of hereditary angioedema KalVista...

Sorry! Image not available at this time

SCOPOLAMINE patch, extended release [Zydus Lifesciences Limited]

nlm.nih.gov - 06/Sep 04:00

Updated Date: Fri, 06 Sep 2024 00:00:00 EDT

Sorry! Image not available at this time

SCOPOLAMINE patch, extended release [Zydus Lifesciences Limited]

nlm.nih.gov - 06/Sep 04:00

Updated Date: Fri, 06 Sep 2024 00:00:00 EDT

‘Significant milestone’ – EBR submits final PMA module to FDA

stockhead.com.au - 29/Aug 21:21

EBR Systems has submitted the final premarket approval (PMA) application module to the US Food and Drug Administration (FDA) for ...

Sorry! Image not available at this time

METFORMIN HYDROCHLORIDE tablet, extended release [Proficient Rx LP]

nlm.nih.gov - 26/Aug 04:00

Updated Date: Mon, 26 Aug 2024 00:00:00 EDT